T1	Participants 270 408	74 children who were scheduled to undergo high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT)
T2	Participants 33 139	granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in children
T3	Participants 184 229	The Japanese Cooperative Study Group of PBSCT
T4	Participants 603 735	The diagnosis included acute lymphoblastic leukemia (ALL) (n = 27), neuroblastoma (n = 29), and miscellaneous solid tumors (n = 18).
T5	Participants 1008 1158	11 patients were excluded due to disease progression before PBSCT (n = 6) or a low number of harvested cells (n = 5), leaving 63 patients for analysis
T6	Participants 1703 1830	Five patients (two in the treatment group and three in the control group) were subsequently removed due to protocol violations.
T7	Participants 1831 1859	All patients survived PBSCT.
T8	Participants 3389 3414	children undergoing PBSCT
